Diagnosis and Reporting of Dysplastic (Atypical, Clarks) Nevi – a Reassessment

Diagnosis and Reporting of Dysplastic (Atypical, Clarks) Nevi – a Reassessment

Eric Schloss, M.D., FRCP(C), Clinical Professor1, Jaggi Rao, M.D., FRCP(C), Clinical Professor2, Marianne Hrabok, Ph.D.3

1Dermatology & Dermatopathology, Faculty of Medicine, University of Alberta;
2Dermatology, Faculty of Medicine, University of Alberta;
3Faculty of Medicine, University of Alberta Faculty of Medicine, University of Calgary.

This article on dysplastic nevi was compiled and written in August 2004 but never published in a print journal. It is our opinion that now, 15 years later, the same conclusions documented in the initial article still exist. In fact, the further studies and reports strongly support the lack of malignancy (nor evidence of pre-cursors of malignancy) in correctly histologically diagnosed junctional or compound dysplastic nevi and the lack of need of re-excision of these nevi in almost all cases. 1,2,3,4

Keywords: dysplastic, melanoma, pathology

Free Full-text PDF

How to cite this article:
Eric Schloss, Jaggi Rao, Marianne Hrabok. Diagnosis and Reporting of Dysplastic (Atypical, Clarks) Nevi – a Reassessment .American Journal of Dermatological Research and Reviews, 2020, 3:23. DOI: 10.28933/ajodrr-2020-02-1905


1. Clark W. W. Jr., Reimer R. R. Greene M. H. et al: Origin of Familial Malignant Melanomas from Heritable Melanocytic Lesions- the BK Mole Syndrome. Arch Dermatol. 114: 732 1978.
2. Consensus development conference on precursors to malignant melanoma. 24 26 October 1983 Washington D.C. JAMA 251: 1864 1984.
3. Salopek Thomas G. The Dilemma of the Dysplastic Nevus. Clin 20 (2002) 617 628.
4. McBride A., Rivers J.K., Knopf A.W., Cocerell C. J., Bart R. S., Grin C.M., Silverman M. K. and Vossaert K.A. Clinical Features of Dysplastic Nevi. Dermatologic Clinics October 1991 pp. 717 722.
5. Kelly J.W., Yeatman J. M., Regalia C., et al. A High Incidence of Melanoma Found in with Multiple Dysplastic Nevi by photographic surveillance. Med. J. Australia; 167: 191-94.
6. Tucker M.A., Hapern A., Holly E.A., et al. Clinically Recognized Dysplastic Nevi. A Central Factor for Cutaneous Melanomas. JAMA 1997:277 1439-44.
7. Sea James A., Jr. Dysplastic Nevi and the Dysplastic Nevus Syndrome. Dermatologics Clinics January 1992 P. 189-201.
8. Hollern, A.C., Guerry 4thD, Elder D.E., et al. Natural history of Dysplastic Nevi. J. Am. Acad. Dermatol. 1993: 29: 51-7.
9. Clark W. H. Jr., Elder D.E., Guerry D., et al. A Study of Tumour Progression: The Precursor Lesions of Superficial Spreading and Nodular Malignant Melanoma. Hum. Pathol 15:1147 1984.
10. Greene M.H., Clark W. H. Jr., Tucker M.A. Acquired Precursors of Cutaneous malignant. The familial dysplastic nevus syndrome. N. Engl. J. Med. 312:91 1985.
11. Elder D.E., Guerry D., Epstein et al Dysplastic nevus syndrome: A Phenotypic association of sporadic cutaneous melanoma. Cancer 46 1787 1980.
12. Elder D.E., Kraemer K.H., Green M.H. et al The dysplastic nevus syndrome our definition. Am. J. Dermatopathol. 4: 455 1982.
13. Cohen M. H., Cohen B.J., Shotkin J.D. et al Surgical Prophylaxis of Malignant Melanoma. Ann Surg 1991 213:308-14.
14. Tucker M.A., Frasser M.C., Goldstein A.M. et al A natural history of Melanomas and Dysplastic Nevi: An Atlas of lesions in melanoma prone families. Cancer 94: 3192-3209 2002 and Yearbook of Dermatology and Dermatologic Surgery 2003 429-30.
15. NIH Consensus development conference. Diagnosis and Treatment of Early Melanoma. Jan. 27-29 1992: JAMA 268: 1314-1319.
16. Bergman W., VanVoorst Vader P.C., Reiter D. J. Dysplastic Nevi and the Risk of Melanoma: a guide for patient care. Ned Tijdschr Genesskd 1997: 141-2010.
17. Piepkorn Michaek W. A Prespective on the Dysplastic Nevus. Pathology State of the Art. Vol. 2, No. 2 1994 p. 259 279.
18. Holly E.A., Kelly J. W., Shpall S.N., Chiu S. H. Number of Melanocytic Nevi is a Major Risk Factor for Malignant Melanoma. J. Am. Acad. Dermatol. 17:459 468 1987.
19. Ackerman A. B. Dysplastic Nevus. Am J. Surg. Pathol. 2000 24 – 757-8.
20. de Wit P.E. van’t Hof-Grootenboer, B., Ruiter D. J et al Validity of histopathologic criteria Used for diagnosing dysplastic nevi: an intraobserver study by the pathology subgroup of the EORTC Malignant Melanoma Cooperative Group. EVR. J. Cancer 1993 29A: 831-9.
21. Weinstock M.A., Barnhill, R.L., Rhodes A.R. et al Reliability of the histopathologic Diagnosis of melanocytic dysplasia. The Dysplastic Nevus Panel Arch. Dermatol. 1997: 133; 953-8.
22. Piepkorn M.W., Bornhill, R.L., Carmen-Albright, L.A. et al A multi-observer population analysis of histologic dysplasia in melanocytic nevi. J. Cutan. Path. 19: 542 1992.
23. Shea C.R., Vollmer R.T., Prieto, V.E. Correlating architectural disorder and cytologic atypia in Clark/dysplastic/melanocytic nevi. Hum. Pathol. 1999: 30 : 500-5.
24. Pozo L., Naasem, Cerco R. et al Critical analysis of histologic criteria for grading atypical (dysplastic) Melanocytic nevi. Am. J. Clin. Pathol. 2001: 115: 194-204.
25. a) Piepkorn M., Meyer L.J., Gollgar D. et al The dysplastic melanocytic nevus: A prevalent lesion that correlates poorly with the clinical phenotype. J. Am. Acad. Dermatol 20: 407-415 1989.
25. b) Sagebiel R. W. The dysplastic melanocytic nevus. J. Am. Acad. Dermatol. 20: 496-501 1989.
26. Klem L.J., Barr R. J. Histologic atypia in clinically benign nevi. J. Am. Acad. Dermatol. 22:275 1990.
27. Kelly J.W., Crutcher W.H., Sagebiel R.W. Clinical Diagnosis of dysplastic melanocytic nevi. J. Am. Acad. Dermatol. 14: 1044-1052. 1986.
28. Grob J.J., Androac, Romeno M.H. et al Dysplastic naevus in non-familial melanoma – A Clinicopathologic study of 101 cases. Br. J. Dermatol 118: 745-752 1988.
29. Ahmed I., Piepkorn M.W., Robkin S. et al Histologic characteristic of dysplastic nevi: Limited Association of congenital histologic criteria with melanoma risk group. J. Am. Acad. Dermatol. 22: 727-33 1990.
30. Cohen L.M., Hodges J. Owen L.G. et al Atypical Melanocytic nevi: clinical and histopathologic Predictors of residual tumour at re-excisions. J. Am. Acad. Dermatol. 1992: 27: 701-6.
31. Ackerman A. Bernard, Cerroni Lorenzo, Kerl Helmut. Pitfalls in Histopathologic Diagnosis Malignant Melanoma. Lea and Febiger 1994.
32. Le Boit Philip E. Simulants of malignant melanoma. A Rogue Gallery of Melanocytic and Nonmelanocytic imposters p. 195-258. Pathology: State of the Art Revies. Vol 2. No.2 1994.
33. Ackerman A.B., Milde P. Naming acquired melanocytic nevi. Common and dysplastic, normal and atypical, or Unna, Miescher, Spitz, and Clark? Am. J. Dermatopathol. 14:447-453 1992.
34. McCalmont Timothy H. The Clinical Context: A Tool for Fine Tuning. Objective Histological Diagnosis of Pigmented Lesions. P. 149 Malignant Melanoma and Melanocytic Neoplasm. State of the Art Reviews edited by Philip E. Le Boit. Vol 2, Number 2, 1994.
35. Roth M.E., Grant-Kels J.M., Ackerman A.B. et al The histopathology of dysplastic nevi: Controversy. Am. J. Dermatopathol. 13:38 1991.

Terms of Use/Privacy Policy/ Disclaimer/ Other Policies:
You agree that by using our site, you have read, understood, and agreed to be bound by all of our terms of use/privacy policy/ disclaimer/ other policies (click here for details).

This work and its PDF file(s) are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.